Skip to main content
. 2014 Mar 13;55(3):167–171. doi: 10.4111/kju.2014.55.3.167

TABLE 5.

Pathological findings in men with disease progression

graphic file with name kju-55-167-i005.jpg

PSA, prostate-specific antigen; PSA DT, prostate-specific antigen doubling time.